News

SAN DIEGO, March 27, 2023 /PRNewswire/ — Today, PrecisePK, an industry-trusted Bayesian Model-Informed Precision Dosing (MIPD) software, reports its technology is being implemented in many of South Korea’s largest health systems. PrecisePK had secured a […]

Eplontersen met co-primary endpoints demonstrating sustained reduction in TTR and benefits in neuropathy and quality of life through 66 weeks 35 and 66-week data to be presented at the American Academy of Neurology (AAN) Annual […]

SAN DIEGO, March 24, 2023 /PRNewswire/ — CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent consumer wellness company specializing in hemp extracts and other proven, science-backed natural ingredients and […]

In a letter to shareholders, Icahn says Illumina’s board sought additional directors & officers protection before embarking on a “value destructive war with powerful antitrust regulators” by acquiring cancer test maker Grail for $7.1 billion. […]

SAN DIEGO, March 24, 2023 /PRNewswire/ — Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, issued the following statement in response to a letter from Carl Icahn dated March 24, […]

First in human study will evaluate safety, tolerability, and pharmacokinetic parameters of NRL-1049, a Rho kinase (ROCK) inhibitor SAN DIEGO, Calif., March 24, 2023 /PRNewswire/ — Neurelis, Inc., announced the first two cohorts dosed in […]

SAN DIEGO–(BUSINESS WIRE)–Biocept, Inc. (Nasdaq: BIOC), a leading provider of molecular diagnostic assays, products and services, announces enrollment of the first patient in the FORESEE clinical trial with the Company’s proprietary cerebrospinal fluid assay CNSide […]

Transformative Next Generation Sequencing (NGS) Innovation expands access to genomic testing and enables personalized medicine for patients with Tuberculosis (TB) CAPE TOWN, South Africa, March 24, 2023 /PRNewswire/ — Illumina Inc. (NASDAQ: ILMN), a global […]

LA JOLLA, Calif.–(BUSINESS WIRE)—- $EQ–Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company leveraging a deep understanding of immunobiology to develop novel therapeutics to treat severe autoimmune and inflammatory disorders with high unmet medical need, today […]

The Company is seeking strategic opportunities to advance the development of this program SAN DIEGO, March 23, 2023 /PRNewswire/ — CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent consumer […]

SAN DIEGO, March 23, 2023 /PRNewswire/ — Sunfish, a fintech company founded last year, aims to make fertility treatments more accessible and has recently designed a new product to help reduce the cost of In […]

SAN DIEGO–(BUSINESS WIRE)–Vividion Therapeutics, Inc., a biopharmaceutical company utilizing novel discovery technologies to unlock high value, traditionally undruggable targets with precision therapeutics for devastating cancers and immune disorders, and a wholly owned and independently operated […]

If approved, tofersen will be the first treatment targeting a genetic cause of ALS and the next marketed Ionis-discovered antisense medicine FDA decision expected by April 25, 2023 CARLSBAD, Calif., March 22, 2023 /PRNewswire/ — […]

CARLSBAD, Calif., March 22, 2023 /PRNewswire/ — DrTalks.com is pleased to announce the upcoming Reverse Inflammaging Body and Mind Longevity Medicine Summit from April 25th to May 2nd, 2023. The summit will be hosted by […]

SAN DIEGO, March 22, 2023 /PRNewswire/ — New premium cocktail and spirits company Club Kokomo Spirits and Speakeasy Co. have announced a distribution partnership, making the California-born brand immediately available to consumers across 34 Sates. […]

LA JOLLA, Calif. & LEON, Spain–(BUSINESS WIRE)–Technosylva Inc., the leading wildfire science and technology company that operationalizes wildfire science, providing proven wildfire risk analysis solutions to enhance daily decision making for fire agencies and electric […]

SAN DIEGO–(BUSINESS WIRE)–A JAMA Psychiatry study, led by Jarratt D. Pytell, MD, MHS, Department of Medicine, University of Colorado School of Medicine, and co-authored by Brendan Saloner, PhD, Johns Hopkins Bloomberg School of Public Health, […]

Award supports design and preclinical testing of pediatric stent SAN DIEGO, March 22, 2023 /PRNewswire/ — Starlight Cardiovascular, Inc., a medical device company developing pediatric cardiovascular devices, announced that it has been awarded a Small […]